{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:28:47Z","timestamp":1753892927236,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Network meta-analysis of deaths from various underlying diseases after COVID-19 infection. This study included more than 10 research centers with the same level of care. In total, 1,676 subjects were included in our study, including 1,122 men and 554 women, patients diagnosed with COVID-19, and combined with underlying diseases; provided data on the number of deaths from related diseases, such as hypertension, diabetes, heart disease, cerebrovascular disease, malignant tumor, chronic kidney disease, chronic liver disease, and respiratory disease. The comparison RR between hypertension and different diseases shows that it is (RR = 2.35, 95% CI: 1.47, 3.98) compared with diabetes, compared with coronary heart disease (RR = 2.57, 95% CI: 1.5, 4.4), compared with cerebrovascular disease (RR = 3.68, 95% CI: 1.87, 7.29), compared with malignant tumor (RR = 6.35, 95% CI: 3.45, 11.97), and compared with chronic kidney disease (RR = 5.53 95% CI: 3.04, 10.34), compared with chronic liver disease (RR = 15.51, 95% CI: 5.26, 50.98), compared with respiratory diseases (RR = 4.35, 95% CI: 2.37, 7.65), RR values are &amp;gt;1, which is statistically significant. The surface under the cumulative ranking curve (SUCRA) showed that the ranking of disease mortality from high to low was hypertension&amp;gt; diabetes&amp;gt; heart disease&amp;gt; cerebrovascular disease&amp;gt; respiratory disease&amp;gt; chronic kidney disease&amp;gt; malignant tumor&amp;gt; chronic liver disease. The study that hypertension, diabetes, and heart disease are the top three risk factors for patients infected with COVID-19, and management of these patients should be strengthened to improve the prognosis of patients. Ethical approval and patient consent are not required as this study is a meta-analysis based on published studies. The results of this network meta-analysis will be submitted to a peer-reviewed journal for the publication.<\/jats:p>","DOI":"10.3389\/fpubh.2022.959073","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T06:55:57Z","timestamp":1661410557000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Network meta-analysis of deaths from various underlying diseases after COVID-19 infection"],"prefix":"10.3389","volume":"10","author":[{"given":"Jinqiang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/molecules26010039","article-title":"COVID-19: a global challenge with old history, epidemiology and progress so far","volume":"26","author":"Khan","year":"2021","journal-title":"Molecules."},{"key":"B2","unstructured":"Coronavirus resource centerJohns Hopkins University & Medicine"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","volume":"323","author":"Sanders","year":"2020","journal-title":"Jama."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/s1473-3099(20)30773-8","article-title":"What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2","volume":"21","author":"Hodgson","year":"2021","journal-title":"Lancet Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"729559","DOI":"10.3389\/fpubh.2021.729559","article-title":"Efficacy of COVID-19 treatments: a bayesian network meta-analysis of randomized controlled trials","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Public Health."},{"key":"B6","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"Jama."},{"key":"B7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/s2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","article-title":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy","volume":"180","author":"Grasselli","year":"2020","journal-title":"JAMA Intern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1093\/cvr\/cvaa284","article-title":"Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities","volume":"116","author":"Bienvenu","year":"2020","journal-title":"Cardiovasc Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1080\/13685538.2020.1774748","article-title":"Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies","volume":"23","author":"Parohan","year":"2020","journal-title":"Aging Male."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/s0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/gerona\/glaa183","article-title":"Preexisting comorbidities predicting COVID-19 and mortality in the UK biobank community cohort","volume":"75","author":"Atkins","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ijid.2020.11.163","article-title":"Severe COVID-19 infection and pediatric comorbidities: a systematic review and meta-analysis","volume":"103","author":"Tsankov","year":"2021","journal-title":"Int J Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.medin.2020.04.006","article-title":"Ethical recommendations for a difficult decision-making in intensive care units due to the exceptional situation of crisis by the COVID-19 pandemia: a rapid review and consensus of experts","volume":"44","author":"Rubio","year":"2020","journal-title":"Med Intensiva."},{"key":"B16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijid.2021.11.009","article-title":"Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis","volume":"114","author":"Zheng","year":"2021","journal-title":"Int J Infect Dis."},{"key":"B17","article-title":"Analysis of clinical characteristics and death risk factors in patients with severe\/critical new coronavirus pneumonia","volume-title":"J Microcircul","author":"Liu","year":"2021"},{"key":"B18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3969\/j.issn.1000-3614","article-title":"Summary of the 2018 report on cardiovascular diseases in China","volume":"34","author":"Hu","year":"2019","journal-title":"Chin Circ J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.diabet.2018.08.008","article-title":"Burden of diabetes, hyperglycaemia in China from to 2016: Findings from the 1990 to 2016, global burden of disease study","volume":"45","author":"Liu","year":"2019","journal-title":"Diabetes Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3969\/j.issn.1006-3110.2021.08.013","article-title":"Analysis of risk factors for death from novel coronavirus pneumonia","volume":"28","author":"Yin","year":"2021","journal-title":"Pract Prevent Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/wevj11040067","article-title":"Investigation of thermal effects in different lightweight constructions for vehicular wireless power transfer modules","volume":"11","author":"Zimmer","year":"2020","journal-title":"World Electr Veh J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/circulationaha.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1111\/jcmm.12573","article-title":"Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats","volume":"19","author":"Klimas","year":"2015","journal-title":"J Cell Mol Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/S2589-7500(20)30289-2","article-title":"Renin\u2013angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis","volume":"3","author":"Morales","year":"2021","journal-title":"Lancet Digit Health."},{"key":"B25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/s2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/s2213-8587(20)30271-0","article-title":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study","volume":"8","author":"Holman","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of Covid-19 in New York city","volume":"382","author":"Goyal","year":"2020","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41574-020-00435-4","article-title":"COVID-19 and diabetes mellitus: from pathophysiology to clinical management","volume":"17","author":"Lim","year":"2021","journal-title":"Nat Rev Endocrinol."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.959073\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T06:56:01Z","timestamp":1661410561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.959073\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":29,"alternative-id":["10.3389\/fpubh.2022.959073"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.959073","relation":{},"ISSN":["2296-2565"],"issn-type":[{"type":"electronic","value":"2296-2565"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"article-number":"959073"}}